CSG’s Market Mismatch: Record Orders and Index Promotion Meet a Bearish Trend

CSG stock tumbled 60% despite record Q1 revenue and €17bn backlog. AMX index inclusion from Monday may help stabilize near 52-week low of €13.65.

The Czechoslovak Group is delivering some of its strongest operational numbers on record, yet its stock keeps falling. Over 60% has been wiped off the share price since January, and the equity closed Friday at €14.28 — barely 4.6% above the 52-week trough of €13.65. The sell-off has accelerated recently, with a 25% loss in the past month alone, pushing the relative strength index to 35.3, a level that typically signals territory close to oversold.

The technical picture paints a stark divide. The 50-day moving average stands at €17.56, while the 100-day average is even higher at €23.25 — both well above Friday’s close. That means any bounce would need to cover a gap of at least 23% just to reclaim the shorter-term trendline. The annualised 30-day volatility of 55.75% suggests sharp swings are likely to persist.

Yet the fundamental story tells a very different tale. First-quarter 2026 revenue rose 13.8% to €1.54 billion, with the defence segment alone expanding 26.5%. The order backlog swelled 15.1% to €17 billion, supported by a negotiation pipeline worth another €27 billion. Management has reaffirmed its full-year forecast: revenue between €7.4 billion and €7.6 billion, an operating EBIT margin of 24–25%, and net leverage below 1.3 times EBITDA by year-end.

New business continues to roll in. Early June saw two large contracts for mechanical and electronic fuzes for large-calibre ammunition, awarded by two European NATO members, with total value in the high double-digit millions. Separately, CSG joined forces with South Africa’s Reunert to create Fuchs Electronics Europe in Slovakia, a joint venture aimed at building European production capacity for critical defence components. The company also lifted its stake in Alzchem Group to 20%.

Against this backdrop, the equity’s inclusion in the Euronext AMX index — effective from Monday — could inject some much-needed demand. Index-tracking funds are required to buy the stock, potentially offsetting some of the selling pressure that has driven it so low. But the timing is awkward: the AMX promotion comes as the stock sits near its floor, and with no fresh company earnings due until 7 August, the trading pattern will be driven largely by order book dynamics and macro sentiment.

This week’s economic calendar may influence the wider risk appetite for European industrial and defence names. The EU Commission releases its flash consumer confidence index for June on Monday, and the ECB’s economic bulletin is due on Wednesday. While these data points won’t dictate CSG’s direction alone, they help shape the environment in which the stock trades.

For now, the key test is simple: can the €13.65 support hold? If the AMX rebalancing attracts enough buying interest to pull the stock back toward the 50-day average, it would mark a first step toward stabilizing a share that has lost over half its value from the 52-week high. Until then, the gulf between a record backlog and a battered stock price remains the market’s most puzzling feature.